Allspring Global Investments
NTLA icon

Allspring Global Investments’s Intellia Therapeutics NTLA Stock Holding History

Allspring Global Investments’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Buy
20,007
+767
+4% +$10.7K ﹤0.01% 1546
2026
Q1 		$255K Buy
19,240
+1,990
+12% +$25.3K ﹤0.01% 1559
2025
Q4 		$159K Buy
17,250
+1,333
+8% +$18.4K ﹤0.01% 1596
2025
Q3 		$299K Sell
15,917
-21
-0.1% -$259 ﹤0.01% 1485
2025
Q2 		$157K Sell
15,938
-860
-5% -$7.06K ﹤0.01% 1564
2025
Q1 		$112K Buy
16,798
+3,935
+31% +$39.7K ﹤0.01% 1690
2024
Q4 		$157K Buy
12,863
+1,582
+14% +$24.7K ﹤0.01% 1692
2024
Q3 		$232K Buy
11,281
+394
+4% +$9.08K ﹤0.01% 1650
2024
Q2 		$244K Buy
10,887
+1,993
+22% +$47.5K ﹤0.01% 1670
2024
Q1 		$245K Buy
8,894
+750
+9% +$20.8K ﹤0.01% 1663
2023
Q4 		$248K Buy
8,144
+582
+8% +$16.7K ﹤0.01% 1651
2023
Q3 		$239K Sell
7,562
-107
-1% -$4.15K ﹤0.01% 1716
2023
Q2 		$313K Buy
7,669
+3,393
+79% +$138K ﹤0.01% 1678
2023
Q1 		$159K Sell
4,276
-816
-16% -$32K ﹤0.01% 1885
2022
Q4 		$178K Sell
5,092
-65
-1% -$3.09K ﹤0.01% 1865
2022
Q3 		$288K Sell
5,157
-293
-5% -$18.2K ﹤0.01% 1710
2022
Q2 		$282K Sell
5,450
-25,046
-82% -$1.27M ﹤0.01% 1723
2022
Q1 		$2.22M Sell
30,496
-1,520
-5% -$129K ﹤0.01% 1452
2021
Q4 		$3.79M Buy
+32,016
New +$4.01M ﹤0.01% 1275

Other funds holding NTLA

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Allspring Global Investments's NTLA Position: Q2 2026 in Review

Allspring Global Investments increased its Intellia Therapeutics (NTLA) stake by 4% in Q2 2026, buying an estimated $10.7K and bringing the position to 20,007 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Allspring Global Investments first reported a position in NTLA in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.79M in Q4 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Allspring Global Investments held 20,007 shares of Intellia Therapeutics worth $345K as of Q2 2026.
  • Allspring Global Investments bought 767 Intellia Therapeutics shares in Q2 2026, an estimated $10.7K.
  • Intellia Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1546 holding.
  • Allspring Global Investments first reported a position in Intellia Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Intellia Therapeutics position peaked at $3.79M in Q4 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.